Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cynthia Bender, Luke Maese, Maria Carter-Febres & Anupam Verma. (2021) Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review. Blood and Lymphatic Cancer: Targets and Therapy 11, pages 25-40.
Read now
Read now
Lisa Figueiredo, Peter D. Cole & Richard A. Drachtman. (2016) Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. coli-derived asparaginase. Expert Review of Hematology 9:3, pages 227-234.
Read now
Read now
Wendy Stock, Dan Douer, Daniel J. DeAngelo, Martha Arellano, Anjali Advani, Lloyd Damon, Tibor Kovacsovics, Mark Litzow, Michael Rytting, Gautam Borthakur & Archie Bleyer. (2011) Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel. Leukemia & Lymphoma 52:12, pages 2237-2253.
Read now
Read now
Articles from other publishers (18)
Jordan Wallace, Lauren Garner, Carmen Echols, Kynlon Phillips & Jenna Bognaski Kaplan,. (2023) Medication Desensitization: Single Intravenous Bag Method, in 3 Pediatric Patients. The Journal of Pediatric Pharmacology and Therapeutics 28:7, pages 671-673.
Crossref
Crossref
Sofie Seghers, Laure-Anne Teuwen, Michiel Beyens, Dennis De Blick, Vito Sabato, Didier G. Ebo & Hans Prenen. (2023) Immediate hypersensitivity reactions to antineoplastic agents – A practical guide for the oncologist. Cancer Treatment Reviews 116, pages 102559.
Crossref
Crossref
Leiah J. Brigitha, Rob Pieters, Eduard A. Struys, Abdellatif Bakkali & Inge M. van der Sluis. (2022)
Depletion of
d
‐ and
l
‐asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy
. Pediatric Blood & Cancer 69:11.
Crossref
Crossref
Amanie Khairullah, Thomas B. Alexander, Kathleen Wang & Jenna Bognaski Kaplan. (2022) Successful Erwinia asparaginase one‐bag rapid desensitization process in a pediatric patient with acute lymphoblastic leukemia. Pediatric Blood & Cancer 69:5.
Crossref
Crossref
Leiah J. Brigitha, Marta Fiocco, Rob Pieters, Birgitte K. Albertsen, Gabriele Escherich, Elixabet Lopez-Lopez, Veerle Mondelaers, Ajay Vora, Lynda Vrooman, Kjeld Schmiegelow & Inge M. van der Sluis. (2022) Hypersensitivity to Pegylated E.coli asparaginase as first-line treatment in contemporary paediatric acute lymphoblastic leukaemia protocols: a meta-analysis of the Ponte di Legno Toxicity working group. European Journal of Cancer 162, pages 65-75.
Crossref
Crossref
Carly S. Wilder, Zhao Chen & John DiGiovanni. (2021) Pharmacologic approaches to amino acid depletion for cancer therapy. Molecular Carcinogenesis 61:2, pages 127-152.
Crossref
Crossref
David M. Charbonneau, Julien Breault-Turcot, Daniel Sinnett, Maja Krajinovic, Jean-Marie Leclerc, Jean-François Masson & Joelle N. Pelletier. (2017) Tracking Silent Hypersensitivity Reactions to Asparaginase during Leukemia Therapy Using Single-Chip Indirect Plasmonic and Fluorescence Immunosensing. ACS Sensors 2:12, pages 1761-1766.
Crossref
Crossref
S. Roselló, I. Blasco, L. García Fabregat, A. Cervantes & K. Jordan. (2017) Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines. Annals of Oncology 28, pages iv100-iv118.
Crossref
Crossref
David M. Charbonneau, Alexandra Aubé, Natalie M. Rachel, Vanessa Guerrero, Kevin Delorme, Julien Breault-Turcot, Jean-François Masson & Joelle N. Pelletier. (2017)
Development of
Escherichia coli
Asparaginase II for Immunosensing: A Trade-Off between Receptor Density and Sensing Efficiency
. ACS Omega 2:5, pages 2114-2125.
Crossref
Crossref
Jennifer L. McNeer, Archie Bleyer, Valentino Conter & Wendy Stock. 2017. Cancer in Adolescents and Young Adults. Cancer in Adolescents and Young Adults
151
175
.
Boris Gorovits, Adrienne Clements-Egan, Mary Birchler, Meina Liang, Heather Myler, Kun Peng, Shobha Purushothama, Manoj Rajadhyaksha, Laura Salazar-Fontana, Crystal Sung & Li Xue. (2016) Pre-existing Antibody: Biotherapeutic Modality-Based Review. The AAPS Journal 18:2, pages 311-320.
Crossref
Crossref
Lynda M. Vrooman, Ivan I. Kirov, ZoAnn E. Dreyer, Michael Kelly, Nobuko Hijiya, Patrick Brown, Richard A. Drachtman, Yoav H. Messinger, A. Kim Ritchey, Gregory A. Hale, Kelly Maloney, Yuan Lu, Paul V. Plourde & Lewis B. Silverman. (2015)
Activity and Toxicity of Intravenous
Erwinia
Asparaginase Following Allergy to
E
.
coli
‐Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
. Pediatric Blood & Cancer 63:2, pages 228-233.
Crossref
Crossref
Richard H. Ko, Tamekia L. Jones, David Radvinsky, Nathan Robison, Paul S. Gaynon, Eduard H. Panosyan, Ioannis A. Avramis, Vassilios I. Avramis, Joan Rubin, Lawrence J. Ettinger, Nita L. Seibel & Girish Dhall. (2015) Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report. Cancer 121:23, pages 4205-4211.
Crossref
Crossref
Lesleigh S. Abbott, Maria Zakova, Furqan Shaikh, Nisha Shewaramani, Angela Punnett & L. Lee Dupuis. (2015) Allergic Reactions Associated with Intravenous Versus Intramuscular Pegaspargase: A Retrospective Chart Review. Pediatric Drugs 17:4, pages 315-321.
Crossref
Crossref
Stephan Borghorst, Georg Hempel, Sabine Poppenborg, Dieter Franke, Thorsten König & Joachim Baumgart. (2014) Comparative pharmacokinetic/pharmacodynamic characterisation of a new pegylated recombinant E. coli l-asparaginase preparation (MC0609) in Beagle dog. Cancer Chemotherapy and Pharmacology 74:2, pages 367-378.
Crossref
Crossref
Virginie Gandemer, Cécile Pochon, Emmanuel Oger, Jean-Hugues H. Dalle, Gérard Michel, Claudine Schmitt, Eva de Berranger, Claire Galambrun, Hélène Cavé, Jean-Michel Cayuela, Nathalie Grardel, Elizabeth Macintyre, Geneviève Margueritte, Françoise Méchinaud, Pierre Rorhlich, Patrick Lutz, François Demeocq, Pascale Schneider, Dominique Plantaz, Marilyne Poirée & Pierre Bordigoni. (2014) Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol. British Journal of Haematology 165:3, pages 392-401.
Crossref
Crossref
Sara E. Shinnick, Mary L. Browning & Susannah E. Koontz. (2013) Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults. Journal of Pediatric Oncology Nursing 30:2, pages 63-77.
Crossref
Crossref
Andrea WillerJoachim GerßThorsten KönigDieter FrankeHans-Jürgen KühnelGünter Henze, Arendt von Stackelberg, Anja Möricke, Martin Schrappe, Joachim BoosClaudia Lanvers-Kaminsky. (2011) Anti–Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials. Blood 118:22, pages 5774-5782.
Crossref
Crossref